← Intervention Library

Foundations · Research guide

Preventive care that changes decisions—not just a longer checklist

How examinations, baseline records and targeted screening can uncover problems before they are obvious, without treating every abnormal result as disease.

Nara’s current evidence positionVeterinary or clinical context
Research guide

Guide updated 2026-09-24. Evidence assessed 2026-08-12. Canine observational evidence.

The takeaway

Nara’s take.

Good preventive care connects observation to action. The useful question is not how many tests your dog receives, but whether a finding can lead to a decision that improves its life.

How it may work

Earlier information can help, but timing matters

Some problems become easier to recognize when a clinician has an examination, an earlier result and an owner's account of change. A baseline can make a later shift easier to interpret than an isolated number.

Finding something earlier is not automatically beneficial, however. The next step matters: confirming whether the finding is real, deciding whether it needs treatment, and weighing the benefits and burdens of that response.

Sources: [1], [2]

What the research shows

What screening studies actually show

Studies of apparently healthy senior and geriatric dogs have found previously unrecognized abnormalities during structured screening. More recent repeated-screening work shows that new findings can emerge over time even in dogs whose owners consider them healthy.

These are useful detection studies. They are not randomized comparisons showing that one universal schedule reduces mortality. They also do not mean that every flagged result is dangerous or that every test should be repeated at the same interval for every dog.

Sources: [1], [2]

Nara's interpretation

A useful appointment starts before the blood draw

Nara would bring changes in weight, appetite, thirst, movement, sleep and behaviour into the conversation alongside test results. That creates a more informative picture than a laboratory panel alone.

It also helps to ask what would happen after a positive result. A test that cannot change the next decision may be less valuable than examining a painful mouth or investigating a new loss of muscle. More information and better information are not always the same thing.

Evidence informing this guidance: [1], [3]

Nara's practical guidance

What this means for your dog

Nara suggests keeping a concise record of changes, previous results, medicines and supplements, then agreeing a screening plan around age, history and risk. Ask which findings need confirmation and what should prompt an earlier visit rather than waiting for the next routine appointment.

Cost and follow-up burden matter: an unexpected result may lead to repeat sampling, imaging or specialist review. That is a reason to plan testing thoughtfully, not to avoid it. New or progressive symptoms belong in a clinical assessment; a preventive schedule should never become a reason to postpone investigating them.

Evidence informing this guidance: [1], [2], [3]

Follow the evidence

Sources and review notes.

Primary studies, clinical guidance and explicitly labelled sponsor disclosures. A mechanism, an observational association and a treatment result are different kinds of evidence.

Editorial research update: 2026-09-24. These guides build on Nara’s existing source records and a fresh check of accessible primary abstracts, full texts and official pages. This is not an exhaustive systematic review or a new independent clinical review. The evidence assessment retains its own date and status. Practical examples are Nara’s interpretation, not validated treatment protocols.

  1. [1] 2017 · dog · prospective screening cohort

    Results of Screening of Apparently Healthy Senior and Geriatric Dogs

    Willems A, Paepe D, Marynissen S, Smets P, Van de Maele I, Picavet P, Duchateau L, Daminet S. Journal of Veterinary Internal Medicine.

    10.1111/jvim.14587

    Demonstrates substantial detection of previously unrecognized abnormalities in apparently healthy older dogs without testing whether screening improves long-term outcomes.

  2. [2] 2025 · dog · prospective repeated-screening cohort

    Exploring the Importance of Repeated Health Screening in Healthy Older Dogs

    Marynissen S, Mortier F, Duchateau L, Smets P, Daminet S, Paepe D. Journal of Veterinary Internal Medicine.

    10.1111/jvim.70166

    Extends evidence that repeated screening detects new findings while leaving the net-outcome benefit of screening schedules unresolved.

  3. [3] 2021 · dog · longitudinal biochemical-variation study

    Variation in biochemistry test results between annual wellness visits in apparently healthy Golden Retrievers

    Jeffery U et al.. Journal of Veterinary Internal Medicine.

    10.1111/jvim.16021

    Supports within-dog longitudinal interpretation and reference-change concepts.

Keep reading

Connected questions.

Open Nara’s evidence assessment

The guide above explains the topic. This separate record preserves the accepted claim, confidence, limitations and safety context. Publishing an article does not upgrade the science or turn an experimental intervention into a recommendation.

Nara’s evidence view

Veterinary or clinical context

SupportedCanine observational evidenceModerate confidence

The claim we’re evaluating

Veterinary preventive assessment can identify previously unrecognized disease and deliver evidence-based preventive interventions, but current canine evidence does not establish that a generic screening panel or fixed screening frequency itself improves healthspan or lifespan.

Nara’s interpretation

Nara considers preventive veterinary care important, but the category should not be given one undifferentiated scientific score. Screening studies show that apparently healthy dogs—particularly older dogs—can have clinically relevant findings that were not previously recognized. Evidence that finding more abnormalities through a generic panel or a fixed testing cadence itself improves lifespan or healthspan is much less established, so screening, vaccination, dental care, parasite control, and other preventive practices should be rated as separate subclaims.

This is an umbrella assessment. The evidence differs materially depending on the outcome and the specific form of the intervention, so Nara evaluates those narrower claims separately.

How we reached this view

What the evidence shows

Prospective screening studies of apparently healthy senior and geriatric dogs have found substantial numbers of physical-examination, laboratory, and disease findings that were previously unsuspected. Repeated-screening research likewise demonstrates detection of new findings over time. These studies establish diagnostic yield, not the causal effect of screening on downstream morbidity, quality of life, survival, overdiagnosis, or net benefit.

Important limitations

  • Diagnostic yield is not equivalent to improved patient outcome.
  • Screening value depends on the disease, prevalence, test performance, whether earlier treatment improves outcome, and downstream consequences.
  • Broad panels create opportunities for incidental findings, false-positive results, repeated testing, and potentially unnecessary procedures.
  • Evidence from senior-dog screening cannot automatically define an optimal schedule for younger dogs or all breeds.
  • The umbrella includes interventions with very different evidence bases, including vaccination, parasite prevention, dental prevention, reproductive care, physical examination, laboratory screening, and disease-specific testing.

What would change Nara’s view

What would strengthen our view

  • Pragmatic canine trials comparing defined screening strategies with usual care and measuring downstream morbidity, quality of life, treatment benefit, or survival.
  • Disease-specific studies demonstrating that earlier detection through screening leads to better clinical outcomes than detection after symptoms emerge.

What could weaken our view

  • Controlled evidence that broader or more frequent screening produces substantial overdiagnosis, downstream procedural harm, or cost without meaningful clinical benefit.
  • Evidence that frequently detected occult abnormalities rarely alter management or outcome.

What could change our position

  • High-quality evidence of net clinical benefit from a defined owner-independent screening program could support a stronger claim for that specific program.
  • Evidence that a screening strategy causes net harm or fails to improve outcomes despite substantial downstream intervention would support a weaker or potentially concerning position for that subclaim.

Safety and clinical context

  • Screening results require clinical interpretation rather than automated diagnosis from an isolated biomarker.
  • Reference-interval abnormalities can be incidental, transient, or context-dependent.
  • A normal screening panel does not guarantee absence of disease, and an abnormal result does not by itself establish a diagnosis.

Evidence record

Nara position
Veterinary or clinical context
Evidence maturity
Supported
Most direct relevant evidence
Canine observational evidence
Overall confidence
Moderate confidence
Evidence reviewed through
2026-08-12
Assessment date
2026-08-12
Review status
Initial Nara internal evidence assessment
Framework
Nara Evidence Framework v1.0

Anchor sources

01

Results of Screening of Apparently Healthy Senior and Geriatric Dogs

Journal of Veterinary Internal Medicine · 2017 · dog

prospective screening cohort

Demonstrates substantial detection of previously unrecognized abnormalities in apparently healthy older dogs without testing whether screening improves long-term outcomes.

10.1111/jvim.14587

02

Exploring the Importance of Repeated Health Screening in Healthy Older Dogs

Journal of Veterinary Internal Medicine · 2025 · dog

prospective repeated-screening cohort

Extends evidence that repeated screening detects new findings while leaving the net-outcome benefit of screening schedules unresolved.

10.1111/jvim.70166

Your dog’s context

Bring this back to your dog.

Loading your dog’s context…